LAMEA Implantable Cardiac Monitors Market By Indication (Cardiac Arrhythmias, Atrial Fibrillation, Epilepsy & Unexplained Falls), End User (Hospitals, Cardiac Center & Clinics, Ambulatory Surgical Centers)
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the LAMEA Implantable Cardiac Monitors Market
Market Report Description
The Latin America, Middle East and Africa Implantable Cardiac Monitors Market would witness market growth of 8.5% CAGR during the forecast period (2018 – 2024).
The implantable cardiac monitor, which is also referred to as implantable loop recorder, is a tiny insertable device used in continuously monitoring hearth rhythms. The device is mostly placed in the left parasternal area of the chest. The device is also placed in some other parts of body, to minimize psychological impact of surgical scar in anterior chest region, without impairing the performance of the device. Technological advancements in cardiac monitoring devices in area of medical cardiology, improved diagnostics, ease of use, and increased adoption in both hospitals & homecare are key growth factors, which are driving the market growth. Additionally, rising awareness among users about devices and treatment options for cardiac disorders is expected to create lucrative opportunities for the market in the near future.
Based on Indication, the report is segmented into Cardiac Arrhythmias, Atrial Fibrillation and Epilepsy & Unexplained falls. Based on End User, the market is segmented into Hospitals, Ambulatory Surgery centers (ASCs) and Cardiac Center & Clinics. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abiomed, Inc., Abbott Laboratories, Boston Scientific Corporation, Reliant Heart, Inc., Astellas Pharma Inc., Biotronik SE & Co. KG, Agilent Technologies, Inc., Berlin Heart GmbH ,Schiller AG, Jarvik Heart, Inc.
Scope of the Study
- Cardiac Arrhythmias
- Atrial Fibrillation
- Epilepsy & Unexplained falls
By End User
- Ambulatory Surgery Centers (ASCs)
- Cardiac Center & Clinics
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Abiomed, Inc.
- Abbott Laboratories
- Boston Scientific Corporation
- Reliant Heart, Inc.
- Astellas Pharma inc.
- Biotronik SE & Co. KG
- Agilent Technologies, Inc.
- Berlin Heart GmbH
- Schiller AG
- Jarvik Heart, Inc.
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free